phase readout
saveNCT07709637: Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
ACTIVE_NOT_RECRUITINGupdated 4d ago
community read0 votes
Sponsor: LucasBio. Phase: PHASE1. Conditions: COVID-19, COVID-19 (SARS-CoV-2 Infection)
view source ↗
comments(0)
5-min edit window · permanent after that